Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
216 participants
OBSERVATIONAL
2023-05-15
2025-04-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study protocol describes the development and procedure to test the validity of two new screening instruments (REAGERA-S20 and REAGERA-N) to detect abuse of people with dementia. The aims of the study are:
1. To assess the validity of two new self-administered screening tools to detect abusive experiences among people with dementia: the REAGERA-S20 directed at people with dementia and the REAGERA-N directed at the next of kin.
2. To translate and validate a Swedish version of the Risk of Elder Abuse and Mistreatment Instrument (REAMI) that can be used by professional caregivers to estimate risk of maltreatment and abuse of people with dementia.
3. To explore experiences of abuse among people with dementia and their next of kin.
Method People with mild to moderate dementia (n=80) and their next of kin (n=80) are recruited at health and social care facilities providing care to people with dementia. In cases of severe dementia or when the person with dementia is excluded for other reasons, only next of kin is included.
The following steps are used in the data collection
1. Participants fill out the REAGERA-S20 or REAGERA-N individually.
2. Participants are interviewed individually by two different researchers about their abusive experiences. If a participant talks about abusive experiences, a qualitative in-depth interview about those experiences is conducted.
3. A preliminary classification of the participants as abused or not abused, based only on information provided in the individual interview is made.
4. Information provided in the two individual interviews are compared by the researchers. If needed, and with permission obtained individually from the participants, a joint concluding interview is conducted to clarify inconsistencies.
5. A final classification of participants experiences of abuse is made based on the information provided in both interviews.
The validity of the REAGERA-S20/REAGERA-N will be calculated using the following classification of participants made in the interviews as gold standard (aim 1):
For the person with dementia
* Reporting or not reporting abusive experiences during the past 12 months.
* Reporting or not reporting abusive experience earlier in life, i.e. more than 12 months ago.
For the next of kin
* Reporting or not reporting own exposure to abuse by the person with dementia during the past 12 months.
* Reporting or not reporting own perpetration of abuse towards the person with dementia during the past 12 months.
* Reporting or not reporting that the person with dementia has been exposed to abuse by another person during the past 12 months.
* Reporting or not reporting that the person with dementia has been exposed to abuse earlier in life, i.e. more than 12 months ago.
After completion of data collection, the REAMI is filled out by a health or social care professional with knowledge about the participant with dementia. Validity of the instrument will be calculated using the information provided in the interview as the gold standard (aim 2).
All interviews are recorded and transcribed verbatim. Analyses of the qualitative interviews will be made to explore experiences of abuse among participants (aim 3).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Path to Prevention of Elder Abuse in Long-term Care. General Population Prevalence Study
NCT06786065
Delirium in Home-dwelling Old People Receiving Home Nursing Care
NCT03066232
Resident-to-Resident Elder Mistreatment Intervention for Dementia Care in Assisted Living
NCT03383289
Evaluation of Prioritized Assessment for Older Patients Living With Frailty Presenting to the Emergency Department
NCT06869148
Comparative Effectiveness of Dementia Care Strategies in Underserved Communities
NCT01459783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
People with dementia
People diagnosed with dementia
No interventions assigned to this group
Next of kin
Next of kin to people with dementia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Next of kin: Being the next of kin to a person with dementia, GDS = 4-7
Exclusion Criteria
* People with dementia: experiencing symptoms that may be exacerbated by study participation or make results less reliable (e.g. paranoia).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Linkoeping University
OTHER_GOV
Jonkoping County Hospital
OTHER
Jonkoping University
OTHER
Region Östergötland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johanna Simmons
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Region Jönköpings Län
Jönköping, , Sweden
Region Östergötland
Linköping, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Simmons J, Floberg E, Casselgren C, Westerlind B, Sandberg J, Swahnberg K, Nagga K, Ludvigsson M, Johansson L. REAGERA-dementia: study protocol for the validation of screening instruments to detect abuse of people with dementia. BMC Geriatr. 2025 Aug 25;25(1):660. doi: 10.1186/s12877-025-06291-z.
Related Links
Access external resources that provide additional context or updates about the study.
Webpage of research program
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20210151
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
941250 and 981144
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2021-05822-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.